OTCPK:VXRTBiotechs
Assessing Vaxart (VXRT) Valuation As Conference Presentation Draws Increased Investor Attention
Vaxart (VXRT) is drawing fresh attention ahead of its scheduled presentation at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026. Investors will be listening for pipeline and funding updates.
See our latest analysis for Vaxart.
Vaxart’s recent 34.83% 7 day share price return and 102.97% 90 day share price return point to building momentum ahead of the conference, even as the 5 year total shareholder return of 87.31% highlights longer term challenges.
If...